Robert C. Doebele, M.D., Ph.D., University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

Robert C. Doebele, M.D., Ph.D., University of Colorado Cancer Center

Caption

Robert C. Doebele, M.D., Ph.D., and colleagues show entrectinib further outpacing crizotinib as first-line therapy against ROS1+ non-small cell lung cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.